What is pathophysiology of Alzheimer?

['Escotatz aquesta pagina']

Quina es la fisiopatologia de l'Alzheimer?

La fisiopatologia de la malautiá d'Alzheimer (MA) es un procediment complèxe que consistís en l'acumulacion de proteïnas anormalas, inflamacion, e disfoncion neuronala.

Las doas caracteristicas principalas de la malautiá son la preséncia de placas de beta amiloïda (Aβ) e de gropaments neurofibrillars (NFT) dins lo cervèl.

Las placas beta amiloïdas se forman quand de fragments de la proteïna precursora amiloïda (APP) son trencadas per d'enzims per formar de peptids Aβ.

Aqueles peptids s'agregan e forman de fibrillas insolublas que s'acumulant fòra dels neurònas, trencan la comunicacion cellula-a-cellula e menant a la mòrt neuronala.

L'acumulacion de las placas Aβ se pensa èsser un dels primièrs eveniments dins lo desvelopament de la malautiá d'Alzheimer, e se crei que contribuís al procediment neurodegeneratiu.

Los embolhs neurofibrillars se forman quand la proteïna tau ven iperfosforilada e forma de filaments anormals a l'interior dels neuròns.

Aqueles embolhs perturban lo foncionament normal dels microtubuls, que son essencials pel transpòrt dels nutriments e autres materials dins lo neuròn.

Los embolhs acaban per provocar la mòrt dels neuròns tocats.

L'inflamacion tanben ten un ròtle dins la fisiopatologia de la malautiá d'Alzheimer.

Lo sistèma immunitari respond a l'acumulacion de las placas Aβ e NFTs liberant de citoquinas proinflamatòrias, que pòdon agravar lo damatge als neurònas.

Mai, i a d'evidéncias que l'estrès oxidatiu, disfoncion mitocondriala, e lo metabolisme del glucòsa mermat contribuisson a la fisiopatologia de la malautiá d'Alzheimer.

Aqueles factors pòdon menar a un disfoncionament neuronal e a la mòrt, agravant encara lo procediment de la malautiá.

La fisiopatologia de la malautiá d'Alzheimer es una interaccion complèxa de factors multiples que menan fin finala a la baissa progressiva de la foncion cognitiva e a la pèrda de memòria que caracteriza la malautiá.

['Referéncias']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Nemeroff CB: The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Arch Gen Psychiatry. 1999, 56 (11): 991-2.

Skoog I, Kalaria RN, Breteler MM: Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. , 13 Suppl 3 (): S106-14.

Proft J, Weiss N: Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol. 2012, 5 (5): 405-7.

Whitehouse PJ, Hedreen JC, White CL, Price DL: Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983, 13 (3): 243-8.

Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res. , 32 (4-5): 717-22.

Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. , 13 (2-3): 301-13.

Raskind MA, Peskind ER: Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994, 8 Suppl 3 (): 54-60.

Schindler SE, McConathy J, Ances BM, Diamond MI: Advances in diagnostic testing for Alzheimer disease. Mo Med. , 110 (5): 401-5.

Singh VK: Immune-activation model in Alzheimer disease. Mol Chem Neuropathol. , 28 (1-3): 105-11.

['Disclaimer: medecina']

['Aqueste site internet es porgit sonque per tòca educativa e informativa e constituís pas un conselh medical o de servici professional.']

['Las informacions donadas se devon pas utilizar per diagnosticar o tractar un problèma de santat o malautiá, e los que cercan un conselh medical personal se devon consultar amb un mètge autorizat.']

["Notatz que lo malhum neuronal que genèra las responsas a las questions, es subretot inexacte al subjècte del contengut numeric. Per exemple, lo nombre de personas diagnosticadas d'una malautiá especifica."]

["Sempre demandar lo conselh de vòstre mètge o d'un autre provesidor de santat qualificat al subjècte d'una condicion medicala. Jamai non pas considerar los conselhs professionals o lo retard per los cercar a causa de quicòm qu'avètz legit sus aqueste site."]

["Disclaimer: Drech d'autor"]

["Lo Digital Millennium Copyright Act de 1998, 17 U.S.C. § 512 (lo DMCA) prevei de recors pels proprietaris dels dreches d'autor que creson que lo material qu'apareis sus Internet infringe lors dreches segon la lei dels dreches d'autor dels EUA. "]

["Se cresètz de bona fe que quin contengut que siá o quin material que siá mes a dispausicion en relacion amb nòstre sit web o nòstres servicis infringe vòstre drech d'autor, vos (o vòstre agent) podètz nos mandar un avertiment demandant que lo contengut o material siá levat, o que l'accès li siá blocat."]

['Los anoncis se devon mandar per escrich per corrièr electronic (vejatz la seccion "Contacte" per l\'adreça).']

["La DMCA exigís que vòstre avís sus la violacion de copyright inclusís las informacions seguentas: (1) descripcion de l'òbra protegida qu'es l'objècte de la violacion; (2) descripcion del contengut sus que se pretend la violacion e informacion sufisenta per nos permetre de localizar lo contengut; (3) vòstras informacions de contacte, coma vòstra adreça, numèro de telefòn e adreça e-mail; (4) una declaracion que cresètz de bona fe que lo contengut de la mena que se reclama es pas autorizat pel proprietari del copyright, o son agent, o per l'aplicacion de quina lei que siá; "]

["5) una declaracion signada per vos, jos pena de perjure, que las informacions contengudas dins la notificacion son precisas e qu'avètz l'autoritat per far valer los dreches d'autor que se pretendon èsser violats;"]

["e (6) una signatura fisica o electronica del proprietari del copyright o d'una persona autorizada a agir al nom del proprietari. "]

["Lo manca d'inclure totas las informacions çai sus pòt provocar un retard dins lo tractament de vòstra reclamacion."]

['Contacte']

['Mandatz-nos un email amb vòstras questions / suggestions.']

What is pathophysiology of alzheimer?

The pathophysiology of Alzheimer's disease (AD) is a complex process that involves the accumulation of abnormal proteins, inflammation, and neuronal dysfunction.

The two main hallmarks of AD are the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain.

Amyloid-beta plaques are formed when fragments of the amyloid precursor protein (APP) are cleaved by enzymes to form Aβ peptides.

These peptides aggregate and form insoluble fibrils that accumulate outside neurons, disrupting cell-to-cell communication and leading to neuronal death.

The accumulation of Aβ plaques is thought to be one of the earliest events in the development of AD, and it is believed to contribute to the neurodegenerative process.

Neurofibrillary tangles are formed when the protein tau becomes hyperphosphorylated and forms abnormal filaments inside neurons.

These tangles disrupt the normal functioning of the microtubules, which are essential for the transport of nutrients and other materials within the neuron.

The tangles eventually lead to the death of the affected neurons.

Inflammation also plays a role in the pathophysiology of AD.

The immune system responds to the accumulation of Aβ plaques and NFTs by releasing pro-inflammatory cytokines, which can exacerbate the damage to neurons.

Additionally, there is evidence that oxidative stress, mitochondrial dysfunction, and impaired glucose metabolism contribute to the pathophysiology of AD.

These factors can lead to neuronal dysfunction and death, further exacerbating the disease process.

Overall, the pathophysiology of AD is a complex interplay of multiple factors that ultimately lead to the progressive decline in cognitive function and memory loss that characterizes the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

["A l'entorn de"]

["BioMedLib utiliza d'ordinators automatics (algoritmes d'aprendissatge automatic) per generar de parelhs de questions e responsas."]

['Començam amb 35 milions de publicacions biomedicalas de PubMed/Medline. Tanben, paginas web de RefinedWeb.']

['Vejatz "Referéncias" tanben "Disclaimer".']